|LETTER TO THE EDITOR
|Year : 2022 | Volume
| Issue : 4 | Page : 285
Takayasu arteritis - Not to miss eye involvement
Anubhav Chauhan, Deepak Kumar Sharma
Department of Ophthalmology, Shri Lal Bahadur Shastri Government Medical College and Hospital, District Mandi, Himachal Pradesh, India
|Date of Submission||11-Jul-2022|
|Date of Decision||16-Jul-2022|
|Date of Acceptance||17-Jul-2022|
|Date of Web Publication||25-Oct-2022|
Dr. Anubhav Chauhan
Department of Ophthalmology, Shri Lal Bahadur Shastri Government Medical College and Hospital, Ner Chowk, District Mandi, Himachal Pradesh
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Chauhan A, Sharma DK. Takayasu arteritis - Not to miss eye involvement. APIK J Int Med 2022;10:285
We read with great interest the excellent article by Umakanth and Biradar titled “Takayasu arteritis in young female a case report.” We applaud the efforts of the authors in describing the challenges in detail. However, we would like to highlight an important aspect which is missing in the case report. The ocular examination should always be carried out in these patients.
Ocular involvement in the form of Takayasu retinopathy is often seen. It has been classified into four stages by Uyama and Asayma.
- Stage 1 – Distension of veins
- Stage 2 – Microaneurysm formation
- Stage 3 – Arteriovenous anastomoses formation
- Stage 4 – Ocular complications such as cataract, rubeosis iridis, neovascularization, vitreous hemorrhage, anterior ischemic optic neuropathy, central retinal artery occlusion, and ocular ischemic syndrome.
Takayasu retinopathy is seen in up to 37% of patients. Other ocular manifestations include uveitis, sclerokeratitis, amaurosis fugax, macular edema, exudative retinal detachment, optic neuropathy, and anterior and posterior circulation stroke. Treatment for Takayasu arteritis with drugs like steroids may itself result in diminution of vision due to complications such as cataracts, glaucoma, and central serous retinopathy. A thorough ophthalmic evaluation is necessary so as not to miss ocular involvement in patients with Takayasu arteritis.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Umakanth AV, Biradar S. Takayasu arteritis in young female a case report. APIK J Int Med 2022;10:124-7. [Full text]
Peter J, David S, Joseph G, Horo S, Danda D. Hypoperfusive and hypertensive ocular manifestations in Takayasu arteritis. Clin Ophthalmol 2010;4:1173-6.
Johnston SL, Lock RJ, Gompels MM. Takayasu arteritis: A review. J Clin Pathol 2002;55:481-6.
Peter J, Joseph G, Mathew V, Peter JV. Visual loss in Takayasu arteritis – Look beyond the eye. J Clin Diagn Res 2014;8:MD06-7.
Peter J, David S, Danda D, Peter JV, Horo S, Joseph G. Ocular manifestations of Takayasu arteritis: A cross-sectional study. Retina 2011;31:1170-8.